TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data Private Market Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Pendulum Therapeutics Stock

Pendulum Therapeutics Stock

pendulum.coHealthcareFounded: 2012Funding to Date: $112.76MM

Pendulum is a biotechnology company committed to developing novel interventions that target the human microbiome to improve the lives of patients suffering from a variety of diseases.

Buy or sell Pendulum Therapeutics stockLearn more about Pendulum Therapeutics IPO
Register for Details

For more details on financing and valuation for Pendulum Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Pendulum Therapeutics.

Register Today

Team

Management Team

Colleen Cutcliffe Ph.D
Chief Executive Officer, Board Member & Co-Founder
Matthew Murphy JD
General Counsel
James Bullard Ph.D
Co-Founder, Chief Technology Officer & Secretary
John Eid Ph.D
Chief Scientific Officer, Board Member & Co-Founder
Mohan Iyer
Chief Operating Officer
Orville Kolterman
Chief Medical Officer

Board Members

Adam D'Augelli
True Ventures
Peter Hutt JD
Colleen Cutcliffe Ph.D
Hugh Martin
John Eid Ph.D
Roelof Botha
Sequoia Capital

Other companies like Pendulum Therapeutics in the Healthcare sector

Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Acelyrin
Sector
Healthcare
Last Round Est. Valuation
$809.52MM
Colossal Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.01B
Paradromics
Sector
Healthcare
 
 
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Artera
Sector
Healthcare
Last Round Est. Valuation
$396.01MM
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Alzheon
Sector
Healthcare
Last Round Est. Valuation
$1.53B

News

Market Screener 09/20/2019
Whole Biome Announces Corporate Name Change to Pendulum Therapeutics
TechCrunch 06/04/2019
Sequoia-backed Whole Biome wants to heal your gut with medical-grade probiotics – TechCrunch
Whole Biome has pulled in $35 million in Series B financing from a list of investing titans, including Sequoia, Khosla, True Ventures, the Mayo Foundation and AME Ventues — just to name a few. The goal? To heal what ails you using microscopic bugs. Medical science has caught on in the last fe…
FinSMEs 05/30/2019
Whole Biome Raises $35M in Series B Financing | FinSMEs
Whole Biome, a San Francisco, CA-based evidence-based microbiome company, secured $35m in Series B financing. The round brings total funding to $57m

Trending Companies

Frequently Asked Questions

Updated on: Jun 1, 2023